![]() |
Name |
Cyclodecasiloxane, eicosamethyl-
|
Molecular Formula | C20H60O10Si10 | |
IUPAC Name* |
2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20-icosamethyl-1,3,5,7,9,11,13,15,17,19-decaoxa-2,4,6,8,10,12,14,16,18,20-decasilacycloicosane
|
|
SMILES |
C[Si]1(O[Si](O[Si](O[Si](O[Si](O[Si](O[Si](O[Si](O[Si](O[Si](O1)(C)C)(C)C)(C)C)(C)C)(C)C)(C)C)(C)C)(C)C)(C)C)C
|
|
InChI |
InChI=1S/C20H60O10Si10/c1-31(2)21-32(3,4)23-34(7,8)25-36(11,12)27-38(15,16)29-40(19,20)30-39(17,18)28-37(13,14)26-35(9,10)24-33(5,6)22-31/h1-20H3
|
|
InChIKey |
CDNNKGWZSNSADW-UHFFFAOYSA-N
|
|
Synonyms |
Cyclodecasiloxane, eicosamethyl-; 18772-36-6; EICOSAMETHYLCYCLODECASILOXANE; YDP9OL0I11; 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20-icosamethyl-1,3,5,7,9,11,13,15,17,19-decaoxa-2,4,6,8,10,12,14,16,18,20-decasilacycloicosane; UNII-YDP9OL0I11; CYCLOMETHICONE 10; Icosamethyl-cyclodecasiloxane; Eicosamethyl-cyclodecasiloxane; SCHEMBL1087120; DTXSID9066411; Q27294476; 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20-Icosamethylcyclodecasiloxane; 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20-Icosamethylcyclodecasiloxane #; CYCLODECASILOXANE, 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20-EICOSAMETHYL-
|
|
CAS | 18772-36-6 | |
PubChem CID | 519601 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 741.5 | ALogp: | 7.2 |
HBD: | 0 | HBA: | 10 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 92.3 | Aromatic Rings: | 1 |
Heavy Atoms: | 40 | QED Weighted: | 0.238 |
Caco-2 Permeability: | -6.48 | MDCK Permeability: | 0.00016366 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.99 |
Human Intestinal Absorption (HIA): | 0.999 | 20% Bioavailability (F20%): | 0.027 |
30% Bioavailability (F30%): | 0.016 |
Blood-Brain-Barrier Penetration (BBB): | 0 | Plasma Protein Binding (PPB): | 128.66% |
Volume Distribution (VD): | 4.805 | Fu: | 87.08% |
CYP1A2-inhibitor: | 0.12 | CYP1A2-substrate: | 0.967 |
CYP2C19-inhibitor: | 0.845 | CYP2C19-substrate: | 0.977 |
CYP2C9-inhibitor: | 0.865 | CYP2C9-substrate: | 0.99 |
CYP2D6-inhibitor: | 0 | CYP2D6-substrate: | 0.953 |
CYP3A4-inhibitor: | 0.571 | CYP3A4-substrate: | 0.036 |
Clearance (CL): | 2.478 | Half-life (T1/2): | 0.055 |
hERG Blockers: | 0.404 | Human Hepatotoxicity (H-HT): | 0 |
Drug-inuced Liver Injury (DILI): | 0.012 | AMES Toxicity: | 0.017 |
Rat Oral Acute Toxicity: | 0 | Maximum Recommended Daily Dose: | 0.335 |
Skin Sensitization: | 0.957 | Carcinogencity: | 0.012 |
Eye Corrosion: | 1 | Eye Irritation: | 0.996 |
Respiratory Toxicity: | 0.011 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000387 | ![]() |
0.900 | D0H2DQ | ![]() |
0.080 | ||
ENC000386 | ![]() |
0.800 | D03HJK | ![]() |
0.078 | ||
ENC000236 | ![]() |
0.700 | D0Z1ZM | ![]() |
0.078 | ||
ENC000372 | ![]() |
0.600 | D06IGU | ![]() |
0.077 | ||
ENC000374 | ![]() |
0.500 | D06ZUP | ![]() |
0.076 | ||
ENC000385 | ![]() |
0.400 | D02YIZ | ![]() |
0.074 | ||
ENC000375 | ![]() |
0.300 | D04JMQ | ![]() |
0.073 | ||
ENC001271 | ![]() |
0.105 | D0TG7I | ![]() |
0.072 | ||
ENC003081 | ![]() |
0.103 | D0E4SI | ![]() |
0.068 | ||
ENC000373 | ![]() |
0.103 | D0O3YF | ![]() |
0.067 |